IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state kidney disease (ESKD). Founded by Harald Ott in 2013, iviva medical is backed by investors that include Bold Capital Partners, Thynk Capital, and LLC. and is headquartered in Beverly.